분자 품질관리 시장 : 2026년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤드마켓츠)출판년월 : 2022년02월

제품[독립, 기기 고유(PCR, DNA 시퀀스)], 용도(감염증 진단), 분석물 유형, 최종 사용자(병원, 진단 실험실) – 2026년까지의 세계 예측

Molecular Quality Controls Market by Product (Independent, Instrument Specific (PCR, DNA Sequencing)), Application (Infectious Diseases Diagnostic), Analyte Type, End User (Hospitals, Diagnostic Lab) – Global Forecast to 2026

페이지수 268
도표수 224
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period.
분자 품질 제어 시장 규모는 예측 기간 동안 6.7%의 CAGR로 2021년 1억 6400만 달러에서 2026년 2억 2600만 달러로 성장할 것으로 예상됩니다.

The growth of this market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the rising demand for external quality assessment support, increasing government funding to support genomics projects, increasing demand for personalized medicines and declining costs of sequencing procedures and increasing prevalence of infectious diseases, cancer & genetic diseases.
“Independent Controls held the largest share during the forecast period.”
Based on product, the molecular quality control market is segmented into Independent Controls and Instrument Specific Controls. The Independent control segment accounted for the largest share of the molecular quality control market in 2020. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the molecular quality control products market.

“The single analyte control segment held the largest share of the molecular controls market in 2020.”
Based on analyte type, the molecular quality control products market is segmented into Single-analyte type and multi-analyte type. Single-analyte controls are highly preferred by laboratories; this segment accounted for the largest share of the molecular quality control products market in 2020.
“The infectious diseases diagnostic segment held the largest share of the molecular controls market in 2020.”

Based on application, the molecular quality controls market is segmented into infectious disease diagnostics, oncology testing, genetic testing, and other applications. The infectious disease diagnostics segment accounted for the largest share of the molecular quality controls market in 2020. The large share of this segment is attributed to the development of advanced assays for infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases.
“Diagnostic Laboratories is the largest end user segment in the molecular quality control market in 2020”
The key end users of molecular quality controls studied in this report include diagnostic laboratories, hospitals, IVD Manufacturers and CROs Academic & Research Institutes, and other end users. The Diagnostic Laboratories segment accounted for the largest share of the molecular quality control market in 2020, increasing number of accredited diagnostic laboratories to provide growth opportunities in the coming years

“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular quality controls market.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.
By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 30%, Europe: 35%, APAC: 15%, Latin America: 10% and Middle East & Africa: 5%

The prominent players in the molecular quality controls market are F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Ortho-Clinical Diagnostics, Inc. (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics, Inc. (US), Microbix Biosystems Inc. (Canada), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Research Coverage:
This report describes and studies the global Molecular quality control market-based product, application, analyte type, end user, and regional level. It provides detailed information regarding the major factors influencing the growth of this market. The report includes an in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments, and MNM overview.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the molecular quality control market. The report analyzes this market by product, analyte type, application, end user, and region
 Market Development: Comprehensive information on the lucrative emerging markets, by products, analyte type, application, end user, and region
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the molecular quality control market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the molecular quality control market


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 29)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 35)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 SECONDARY RESEARCH
2.1.3 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
2.1.3.2 Breakdown of primary sources
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 PRIMARY SOURCES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 7 MOLECULAR QUALITY CONTROLS MARKET: TOP-DOWN APPROACH
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: MOLECULAR QUALITY CONTROLS MARKET (2020)
FIGURE 10 MARKET SIZE ESTIMATION: PARENT MARKET
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MOLECULAR QUALITY CONTROLS MARKET (2021–2026)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MOLECULAR QUALITY CONTROLS MARKET
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 14 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 15 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE MOLECULAR QUALITY CONTROLS MARKET

3 EXECUTIVE SUMMARY (Page No. – 54)
FIGURE 16 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 17 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 19 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR QUALITY CONTROLS MARKET

4 PREMIUM INSIGHTS (Page No. – 58)
4.1 MOLECULAR QUALITY CONTROLS: MARKET OVERVIEW
FIGURE 21 INCREASING GOVERNMENT FUNDING TO SUPPORT GENOMICS PROJECTS TO DRIVE MARKET GROWTH
4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
FIGURE 22 INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026)
4.3 APAC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY (2020)
FIGURE 23 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MOLECULAR QUALITY CONTROLS MARKET IN 2020
4.4 MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHIC MIX
FIGURE 24 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.5 MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 63)
5.1 INTRODUCTION
FIGURE 26 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Increasing number of accredited clinical laboratories
FIGURE 27 NUMBER OF LABORATORIES THAT RECEIVED CLIA ACCREDITATION, BY ACCREDITATION ORGANIZATION (2021)
5.1.1.2 Growing adoption of third-party quality controls
5.1.1.3 Increasing government funding to support genomics projects
TABLE 3 GOVERNMENT FUNDING TO SUPPORT GENOMICS
5.1.1.4 Increasing demand for personalized medicines and declining costs of sequencing procedures
FIGURE 28 COST OF SEQUENCING PROCEDURES, 2016-2021
5.1.1.5 Increasing prevalence of infectious diseases, cancer, & genetic diseases
FIGURE 29 GLOBAL CANCER INCIDENCE, 2020 VS. 2024
5.1.1.6 Rising demand for external quality assessment support
5.1.2 RESTRAINTS
5.1.2.1 Additional costs involved in quality control and budget constraints in hospitals and laboratories
5.1.2.2 Unfavorable reimbursement scenario for molecular tests
5.1.3 OPPORTUNITIES
5.1.3.1 Rising demand for multi-analyte controls
5.1.3.2 Growth opportunities in emerging countries
5.1.4 CHALLENGES
5.1.4.1 Lack of mandatory regulations for clinical laboratory accreditation in several emerging countries
5.1.4.2 Changing regulatory framework

6 INDUSTRY INSIGHTS (Page No. – 72)
6.1 INDUSTRY TRENDS
6.1.1 INCREASING DEMAND FOR THIRD-PARTY INDEPENDENT QUALITY CONTROLS
TABLE 4 THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
6.1.2 CONSOLIDATION OF LABORATORIES
6.2 PRICING ANALYSIS
TABLE 5 PRICING ANALYSIS OF MOLECULAR QUALITY CONTROL PRODUCTS (2021)
FIGURE 30 MOLECULAR QUALITY CONTROL PATENT PUBLICATION TRENDS (JANUARY 2012-JANUARY 2022)
FIGURE 31 MOLECULAR QUALITY CONTROLS: TOP 10 COMPANIES WITH THE HIGHEST PATENT APPLICATIONS (2011-2020)
FIGURE 32 MOLECULAR QUALITY CONTROLS: TOP 10 PATENT OWNERS (2011-2020)
6.3 VALUE CHAIN ANALYSIS
FIGURE 33 VALUE CHAIN ANALYSIS
6.4 SUPPLY CHAIN ANALYSIS
FIGURE 34 SUPPLY CHAIN ANALYSIS
6.5 ECOSYSTEM ANALYSIS
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 MOLECULAR QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.6.1 THREAT OF NEW ENTRANTS
6.6.2 THREAT OF SUBSTITUTES
6.6.3 BARGAINING POWER OF BUYERS
6.6.4 BARGAINING POWER OF SUPPLIERS
6.6.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
6.7 REGULATORY ANALYSIS
6.7.1 NORTH AMERICA
6.7.1.1 US
TABLE 7 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
6.7.1.2 Canada
6.7.2 EUROPE
TABLE 8 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
6.7.3 ASIA PACIFIC
6.7.3.1 Japan
6.7.3.2 China
6.7.3.3 India
6.8 TRENDS & DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESS
FIGURE 35 MOLECULAR QUALITY CONTROLS MARKET: TRENDS & DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES
6.8.1 COVID-19 IMPACT ANALYSIS

7 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT (Page No. – 86)
7.1 INTRODUCTION
FIGURE 36 INDEPENDENT CONTROLS SEGMENT TO DOMINATE THE MOLECULAR QUALITY CONTROLS MARKET IN 2026
TABLE 9 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
TABLE 10 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
7.2 INDEPENDENT CONTROLS
7.2.1 A WIDE RANGE OF APPLICATIONS AND REDUCTIONS IN OPERATIONAL COSTS HAVE BOOSTED THE ADOPTION OF INDEPENDENT CONTROLS
TABLE 11 INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 12 INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 INSTRUMENT-SPECIFIC CONTROLS
TABLE 13 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 14 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
7.3.1 POLYMERASE CHAIN REACTION (PCR)
7.3.1.1 Growing use of PCR in proteomics and genomics is a major factor driving market growth
TABLE 15 PCR MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 DNA SEQUENCING & NGS
7.3.2.1 Advancements in sequencing technologies to support market growth
TABLE 16 DNA SEQUENCING & NGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 OTHER TECHNOLOGIES
TABLE 17 OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

8 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE (Page No. – 96)
8.1 INTRODUCTION
FIGURE 37 SINGLE-ANALYTE CONTROLS SEGMENT DOMINATES THE MOLECULAR QUALITY CONTROLS MARKET
TABLE 18 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
8.2 SINGLE-ANALYTE CONTROLS
8.2.1 SIGNIFICANT USE OF SINGLEPLEX ASSAYS IN HOSPITALS IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 19 SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 MULTI-ANALYTE CONTROLS
8.3.1 INCREASING PREFERENCE FOR MULTI-ANALYTE CONTROLS TO FUEL MARKET GROWTH
TABLE 20 EXAMPLES OF MULTI-ANALYTE CONTROLS
TABLE 21 MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

9 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION (Page No. – 101)
9.1 INTRODUCTION
FIGURE 38 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT TO DOMINATE THE MOLECULAR QUALITY CONTROLS MARKET DURING THE FORECAST PERIOD
TABLE 22 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
9.2 INFECTIOUS DISEASE DIAGNOSTICS
9.2.1 GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET GROWTH
TABLE 23 NUMBER OF COVID-19 CASES, BY COUNTRY (2021)
TABLE 24 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 ONCOLOGY TESTING
9.3.1 ONCOLOGY TESTING SEGMENT IS PROJECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
TABLE 25 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 GENETIC TESTING
9.4.1 ADVANCEMENTS IN GENETIC TESTING TO DRIVE MARKET GROWTH
TABLE 26 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2019–2026 (USD MILLION)
9.5 OTHER APPLICATIONS
TABLE 27 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

10 MOLECULAR QUALITY CONTROLS MARKET, BY END USER (Page No. – 109)
10.1 INTRODUCTION
FIGURE 39 DIAGNOSTIC LABORATORIES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 28 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 DIAGNOSTIC LABORATORIES
10.2.1 INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO PROVIDE GROWTH OPPORTUNITIES IN THE COMING YEARS
TABLE 29 MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 HOSPITALS
10.3.1 GROWING PATIENT VOLUME IS DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS AMONG HOSPITALS
TABLE 30 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 IVD MANUFACTURERS & CONTRACT RESEARCH ORGANIZATIONS
10.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH
TABLE 31 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
10.5 ACADEMIC & RESEARCH INSTITUTES
10.5.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET GROWTH
TABLE 32 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
10.6 OTHER END USERS
TABLE 33 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

11 MOLECULAR QUALITY CONTROLS MARKET, BY REGION (Page No. – 117)
11.1 INTRODUCTION
TABLE 34 MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 40 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 Increasing CLIA accreditation for clinical laboratories is driving the market for molecular quality controls in the US
FIGURE 41 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (2018)
TABLE 41 US: KEY MACROINDICATORS
TABLE 42 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 43 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 44 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 45 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 46 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Canada has a well-established and well-funded biomedical research sector
TABLE 47 CANADA: KEY MACROINDICATORS
TABLE 48 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 49 CANADA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 50 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 51 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 52 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY
TABLE 53 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 54 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 55 EUROPE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 56 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 57 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Increasing number of certified laboratories and the rising volume of high-quality tests performed by these laboratories to support market growth in Germany
TABLE 59 GERMANY: KEY MACROINDICATORS
TABLE 60 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 61 GERMANY: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 62 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 63 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 64 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market growth
TABLE 65 FRANCE: KEY MACROINDICATORS
TABLE 66 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 FRANCE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 68 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 69 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 70 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 UK
11.3.3.1 Growth in the life science industry and increased research to drive market growth in the UK
TABLE 71 UK: KEY MACROINDICATORS
TABLE 72 UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 73 UK: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 74 UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 75 UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 76 UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Growing disease prevalence to drive the demand for better and more accurate disease diagnosis in Italy
TABLE 77 ITALY: KEY MACROINDICATORS
TABLE 78 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 ITALY: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 80 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 81 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 82 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth in Spain
TABLE 83 SPAIN: KEY MACROINDICATORS
TABLE 84 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 85 SPAIN: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 86 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 87 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 88 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.6 RUSSIA
11.3.6.1 Increasing acceptance of molecular diagnostics-based personalized medicine to drive market growth
TABLE 89 RUSSIA: DISEASE STATISTICS (2020)
TABLE 90 RUSSIA: POPULATION AND CANCER STATISTICS
TABLE 91 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 92 RUSSIA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 93 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 94 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 95 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 96 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 REST OF EUROPE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 98 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 99 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 100 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 43 ASIA PACIFIC: CANCER PREVALENCE
FIGURE 44 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 101 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 102 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 ASIA PACIFIC: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 104 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 105 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 106 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Well-developed healthcare system and the rising demand for improvements in the quality of IVD test results to drive market growth in Japan
TABLE 107 JAPAN: KEY MACROINDICATORS
TABLE 108 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 109 JAPAN: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 110 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 111 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 112 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Growing access to modern healthcare and government support to boost the market growth in China
TABLE 113 CHINA: KEY MACROINDICATORS
TABLE 114 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 CHINA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 116 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 117 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 118 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rising need to secure NABL accreditations to drive the demand for quality controls in India
FIGURE 45 INDIA: INCREASING NUMBER OF LABS WITH NABL ACCREDITATIONS, 2012–2020
TABLE 119 INDIA: KEY MACROINDICATORS
TABLE 120 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 INDIA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 122 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 123 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 124 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 125 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 126 REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 RISING INCIDENCE OF SEVERAL INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
TABLE 130 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 LATIN AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 132 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 133 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 134 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 GROWING GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET GROWTH
TABLE 135 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2019–2026 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2019–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. – 171)
12.1 MARKET OVERVIEW
12.2 KEY PLAYER STRATEGIES
12.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
12.4 MARKET RANKING ANALYSIS
FIGURE 47 RANK OF COMPANIES IN THE GLOBAL MOLECULAR QUALITY CONTROLS MARKET (2020)
12.5 COMPETITIVE LEADERSHIP MAPPING
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 48 MOLECULAR QUALITY CONTROLS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
12.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 49 MOLECULAR QUALITY CONTROLS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
12.7 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS
FIGURE 50 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE MOLECULAR QUALITY CONTROLS MARKET
12.8 COMPANY GEOGRAPHIC FOOTPRINT
12.8.1 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
TABLE 140 COMPANY END-USER FOOTPRINT (20 COMPANIES)
TABLE 141 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
12.9 COMPETITIVE SITUATION AND TRENDS
12.9.1 MOLECULAR QUALITY CONTROLS MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 142 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
12.9.2 MOLECULAR QUALITY CONTROLS MARKET: KEY DEALS
TABLE 143 KEY DEALS

13 COMPANY PROFILES (Page No. – 190)
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 LGC LIMITED
TABLE 144 LGC LIMITED: BUSINESS OVERVIEW
FIGURE 51 LCG LIMITED: COMPANY SNAPSHOT (2021)
13.1.2 THERMO FISHER SCIENTIFIC
TABLE 145 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 52 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
13.1.3 BIO-RAD LABORATORIES, INC.
TABLE 146 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
13.1.4 MICROBIOLOGICS, INC.
TABLE 147 MICROBIOLOGICS, INC.: BUSINESS OVERVIEW
13.1.5 ABBOTT LABORATORIES
TABLE 148 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 54 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
13.2 OTHER PLAYERS
13.2.1 ROCHE DIAGNOSTICS
TABLE 149 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 55 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2020)
13.2.2 ZEPTOMETRIX, LLC
TABLE 150 ZEPTOMETRIX, LLC: BUSINESS OVERVIEW
13.2.3 QUIDEL CORPORATION
TABLE 151 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 56 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
13.2.4 QNOSTICS
TABLE 152 QNOSTICS: BUSINESS OVERVIEW
13.2.5 MAINE MOLECULAR QUALITY CONTROLS, INC.
TABLE 153 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
13.2.6 RANDOX LABORATORIES LTD.
TABLE 154 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
13.2.7 BIO-TECHNE CORPORATION
TABLE 155 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 57 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021)
13.2.8 FORTRESS DIAGNOSTICS
TABLE 156 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
13.2.9 MICROBIX BIOSYSTEMS
TABLE 157 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
FIGURE 58 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2021)
13.2.10 GRIFOLS, S.A.
TABLE 158 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 59 GRIFOLS, S.A.: COMPANY SNAPSHOT (2020)
13.2.11 ORTHO CLINICAL DIAGNOSTICS
TABLE 159 ORTHO CLINICAL DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 60 ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT (2020)
13.2.12 ANCHOR MOLECULAR
TABLE 160 ANCHOR MOLECULAR: BUSINESS OVERVIEW
13.2.13 SPEEDX PTY. LTD.
TABLE 161 SPEEDX PTY. LTD.: BUSINESS OVERVIEW
13.2.14 SERO AS
TABLE 162 SERO AS: BUSINESS OVERVIEW
13.2.15 SEEGENE INC.
TABLE 163 SEEGENE INC.: BUSINESS OVERVIEW
FIGURE 61 SEEGENE INC: COMPANY SNAPSHOT (2020)
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX (Page No. – 268)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com